Company: LGNZZ
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0000886163-25-000040
Chunk: 0

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-06-09
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2025 Annual Meeting of the Stockholders of Ligand Pharmaceuticals Incorporated (the “ Company”) was held on June 6, 2025 (the “ Annual Meeting”). Set forth below are the final voting results for the actions taken by the stockholders at the Annual Meeting.

Proposal 1. The election of eight members of the Board of Directors of the Company for terms expiring at the 2026 annual meeting of stockholders. In accordance with the results below, each nominee was elected to serve as a director of the Company.

                                      Votes For      Votes Withheld      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────────────
  Jason M. Aryeh                     13,595,137           3,224,879             1,363,582  
  Todd C. Davis                      16,393,716             426,300             1,363,582  
  Nancy R. Gray, Ph. D.              16,470,033             349,983             1,363,582  
  Jason Haas                         16,621,292             198,724             1,363,582  
  John W. Kozarich, Ph. D.           15,684,962           1,135,054             1,363,582  
  John L. LaMattina, Ph. D.          15,961,637             858,379             1,363,582  
  Stephen L. Sabba, M. D.            15,789,883           1,030,133             1,363,582  
  Martine Zimmermann, Pharm. D.      16,666,655             153,361             1,363,582  

Proposal 2. The ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. In accordance with the results below, the selection of Ernst & Young LLP was ratified.

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  17,274,429            906,847            2,322      —                 

Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the